Heitmed

Heitmed is a multinational biomedical technology company that develops medical imaging systems, AI-powered diagnostic software, and digital health platforms. Founded in 2010, it operates in more than 40 countries and maintains research and development centers on three continents. The company focuses on integrating imaging hardware with analytics and cloud-based data management to support clinical decision-making.

History: Heitmed began as a collaboration between engineers and clinicians seeking practical imaging tools. Notable milestones include the 2014 portable HelioScan X ultrasound, the 2016 expansion into MRI-compatible hardware, the 2018 launch of HelioAI for radiology, and the 2021 introduction of HelioCloud for data management. By 2023 it had established partnerships with academic medical centers to evaluate its software prospectively.

Products and services: HelioScan imaging devices (ultrasound and handheld scanners); HelioAI for AI-assisted interpretation; HelioCloud for data integration and analytics; and professional services such as installation, training, and regulatory support.

Global operations: Manufacturing occurs at several facilities with regional offices providing sales, service, and clinical support. Heitmed maintains partnerships with hospitals and research institutions to conduct studies and gather real-world evidence.

Regulation and reception: CE markings are held for EU markets and several products have regulatory clearance in other regions, including select FDA authorizations for diagnostic tools. The company is recognized for progress in AI-assisted imaging while facing common debates over data privacy and algorithm transparency.